Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01231152
NCT01231152
Unknown
Not Applicable

The Relation of Obesity With Metabolic Disorders, Inflammation Markers and Arterial Blood Pressure With Preclinical Target-organ Damage in Children and Young Adolescents.

University of Athens1 site in 1 country80 target enrollmentSeptember 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsObesityCardiovascular Risk Factors

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Athens
Enrollment
80
Locations
1
Primary Endpoint
Blood Pressure levels, Target organ damage (Left Ventricular Hypertrophy, IMT, pulse wave velocity, microalbuminuria), Insulin Resistance
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of the study is to investigate the association of obesity with arterial blood pressure, atherosclerosis, target organ damage (heart, arteries, kidney) and insulin resistance in children and young adolescents.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
December 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Athens
Responsible Party
Principal Investigator
Principal Investigator

George S. Stergiou

Associate Professor of Medicine and Hypertension

University of Athens

Eligibility Criteria

Inclusion Criteria

  • •Overweight (85th\<BMI\<95th percentile) and obese (BMI\>=95th percentile) children and adolescents
  • •No medication treatment (apart from bronchodilators, T4 in euthyroid children)
  • •No severe mental problem
  • •Parents' and patients' signed consent

Exclusion Criteria

  • •Severe chronic or acute cardiac disease or other severe chronic or acute disease
  • •Any acute inflammation
  • •Familial dyslipidemia
  • •Clinical hypothyroidism or other endocrinopathy
  • •Poor compliance.

Outcomes

Primary Outcomes

Blood Pressure levels, Target organ damage (Left Ventricular Hypertrophy, IMT, pulse wave velocity, microalbuminuria), Insulin Resistance

Time Frame: 3 weeks

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Mechanisms Underlying Metabolic Syndrome in ObesityMetabolic SyndromeInsulin ResistancePrediabetes
NCT00579813Philip Kern70
Completed
Phase 3
Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea SyndromeRefractory Hypertension
NCT00746902University Hospital, Grenoble62
Active, not recruiting
Not Applicable
Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic NeuralgiaHerpes Zoster (HZ)
NCT06638177Brigham and Women's Hospital200,000
Completed
Not Applicable
Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi ArabiaObesity and Cardiovascular Risk
NCT05642533Novo Nordisk A/S1,061
Recruiting
Not Applicable
Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsAsthmaObesityMetabolic Syndrome
NCT03215836University of Colorado, Denver50